168 related articles for article (PubMed ID: 26649921)
21. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
Ahn S; Lee IH; Lee E; Kim H; Kim YC; Jon S
J Control Release; 2013 Sep; 170(2):226-32. PubMed ID: 23747732
[TBL] [Abstract][Full Text] [Related]
22. Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin.
Yu W; Jiang G; Zhang Y; Liu D; Xu B; Zhou J
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():187-196. PubMed ID: 28866156
[TBL] [Abstract][Full Text] [Related]
23. Combined Silk Fibroin Microneedles for Insulin Delivery.
Zhu M; Liu Y; Jiang F; Cao J; Kundu SC; Lu S
ACS Biomater Sci Eng; 2020 Jun; 6(6):3422-3429. PubMed ID: 33463180
[TBL] [Abstract][Full Text] [Related]
24. [Development of a novel transdermal delivery system of peptide and protein drugs using microneedle arrays].
Katsumi H; Quan YS; Kamiyama F; Kusamori K; Sakane T; Yamamoto A
Yakugaku Zasshi; 2014; 134(1):63-7. PubMed ID: 24389619
[TBL] [Abstract][Full Text] [Related]
25. Enhanced transdermal lymphatic delivery of doxorubicin via hyaluronic acid based transfersomes/microneedle complex for tumor metastasis therapy.
Yang H; Wu X; Zhou Z; Chen X; Kong M
Int J Biol Macromol; 2019 Mar; 125():9-16. PubMed ID: 30500513
[TBL] [Abstract][Full Text] [Related]
26. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC
J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390
[TBL] [Abstract][Full Text] [Related]
28. Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system.
Hiraishi Y; Nakagawa T; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
Int J Pharm; 2013 Jan; 441(1-2):570-9. PubMed ID: 23137695
[TBL] [Abstract][Full Text] [Related]
29. Long acting hyaluronate--exendin 4 conjugate for the treatment of type 2 diabetes.
Kong JH; Oh EJ; Chae SY; Lee KC; Hahn SK
Biomaterials; 2010 May; 31(14):4121-8. PubMed ID: 20149450
[TBL] [Abstract][Full Text] [Related]
30. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin.
Chen H; Zhu H; Zheng J; Mou D; Wan J; Zhang J; Shi T; Zhao Y; Xu H; Yang X
J Control Release; 2009 Oct; 139(1):63-72. PubMed ID: 19481577
[TBL] [Abstract][Full Text] [Related]
31. Macromolecular delivery into skin using a hollow microneedle.
Wonglertnirant N; Todo H; Opanasopit P; Ngawhirunpat T; Sugibayashi K
Biol Pharm Bull; 2010; 33(12):1988-93. PubMed ID: 21139238
[TBL] [Abstract][Full Text] [Related]
32. Biological activity of AC3174, a peptide analog of exendin-4.
Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
[TBL] [Abstract][Full Text] [Related]
33. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
34. [Preparation and transdermal effect of a tip-loaded bubble-soluble microneedle].
Zhu L; Zhuang J; Zhao Z; Huang Y; Sun J; Liu F; Xue Q; Wu D
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2281-2291. PubMed ID: 35786479
[TBL] [Abstract][Full Text] [Related]
35. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
36. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
[TBL] [Abstract][Full Text] [Related]
37. Transdermal insulin application system with dissolving microneedles.
Ito Y; Nakahigashi T; Yoshimoto N; Ueda Y; Hamasaki N; Takada K
Diabetes Technol Ther; 2012 Oct; 14(10):891-9. PubMed ID: 23013202
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study.
Avcil M; Akman G; Klokkers J; Jeong D; Çelik A
J Cosmet Dermatol; 2020 Feb; 19(2):328-337. PubMed ID: 31134751
[TBL] [Abstract][Full Text] [Related]
39. Glucose-Responsive Insulin Delivery by Microneedle-Array Patches Loaded with Hypoxia-Sensitive Vesicles.
Yu J; Zhang Y; Gu Z
Methods Mol Biol; 2017; 1570():251-259. PubMed ID: 28238142
[TBL] [Abstract][Full Text] [Related]
40. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy.
Kong M; Hou L; Wang J; Feng C; Liu Y; Cheng X; Chen X
Chem Commun (Camb); 2015 Jan; 51(8):1453-6. PubMed ID: 25493296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
